Skip to main content
Internal Medicine Respiratory Medicine

Respiratory Medicine

Recent technological advancements have introduced multiple modalities of artificial intelligence to the study of sarcoidosis, with machine learning, deep learning, and radiomics showing promise in diagnosing and prognosticating.

The second report, and the first in an adult, of acute epiglottitis directly associated with e-cigarettes with no evidence of infection, indicating the need to consider noninfectious primary causes in the differential diagnosis of epiglottitis.

People with primary ciliary dyskinesia may show improved lung function after treatment with inhaled idrevloride in hypertonic saline.

A review of the latest findings pertaining to endobronchial ultrasound and lung cancer staging, with an aim to equip clinicians with evidence-based recommendations and highlight avenues for further research.

The second report, and the first in an adult, of acute epiglottitis directly associated with e-cigarettes with no evidence of infection, indicating the need to consider noninfectious primary causes in the differential diagnosis of epiglottitis.

Four cases highlighting the challenges of managing acute respiratory failure in patients with immune checkpoint inhibitor-induced overlap syndrome, consisting of myasthenia gravis, myositis, and myocarditis.

Nonconventional pulmonary function tests, such as the forced oscillation technique and multiple breath washout, can help detect small airways disease in people with post-acute COVID-19 syndrome.

Episode 5: Next-generation sequencing

Emerging biomarkers in thyroid and non-small cell lung cancers

Next-generation sequencing is a powerful tool that can identify mutations or fusions in a wide range of cancers, enabling physicians to provide targeted therapy to patients and improve outcomes. In this podcast, Professor Andrew Beggs discusses practical aspects of this technique from the clinical viewpoint.

This content is intended only for healthcare providers and was made possible by educational funding provided by Illumina, Inc., and Eli Lilly and Company.

Listen now

Our tailored content service will keep you up to date…

Receive newsletters curated for the busy specialist by our expert editorial team

Expert-led, multiformat program which will address the individualized management of NSCLC, through education on the detection of NTRK gene fusions, current evidence-based guidelines, and new and emerging therapies. Will also include guidance on integrating shared decision making into your clinical practice, drawing on insights from a patient on how best to communicate.

CME: 1.0 AMA PRA Category 1 Credit(s)™

Practical, expert-led digital map designed to guide treatment of ALK- and ROS1-mutation positive NSCLC.